Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine […]
“The past year was an unprecedented one,” says Patrizia Cavazzoni, MD, acting director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), […]
The European Medicines Agency (EMA) has expanded the use and scope of remote source data verification (rSDV) for clinical trials in which patients’ private data are adequately protected, according to […]
Healthy people volunteering to be infected with SARS-CoV-2, in order to help scientists better understand how to tackle the virus, should receive payment—if it is determined that these studies are […]
Calling for a concerted effort to promote diversity in the clinical trials workforce, Association of Clinical Research Professionals (ACRP) Executive Director Jim Kremidas yesterday (February 3) said that now is […]